Janus Henderson Group PLC Praxis Precision Medicines, Inc. Transaction History

Janus Henderson Group PLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.75 - $11.34 $5.83 Million - $37.8 Million	-3,333,943 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$10.21 - $20.29 $88,071 - $175,021	-8,626 Reduced 0.26%	3,333,943 $34 Million
Q4 2021 Feb 14, 2022	BUY	$16.76 - $22.99 $1.06 Million - $1.46 Million	63,404 Added 1.93%	3,342,569 $65.9 Million
Q3 2021 Nov 16, 2021	BUY	$13.15 - $22.56 $3.95 Million - $6.78 Million	300,680 Added 10.1%	3,279,165 $60.6 Million
Q2 2021 Aug 16, 2021	BUY	$18.28 - $33.05 $35 Million - $63.3 Million	1,915,096 Added 180.09%	2,978,485 $54.4 Million
Q1 2021 May 17, 2021	BUY	$29.34 - $60.2 $4.87 Million - $9.99 Million	166,017 Added 18.5%	1,063,389 $34.8 Million
Q4 2020 Feb 16, 2021	BUY	$27.25 - $55.82 $24.5 Million - $50.1 Million	897,372 New	897,372 $49.4 Million

75K

Ticker PRAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,576,100
Market Cap $3.54B
Description
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of ...

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

Stay updated on Janus Henderson Group PLC with notifications on news.